Pfizer Inc (PFE) Stock Analysis

Pfizer Inc (PFE) is a publicly traded company in the HEALTHCARE sector. It trades at $25.57, carries a market capitalization of $146.08B, a price-to-earnings ratio of 19.56, a dividend yield of 0.07%. This page summarizes the public market data, fundamentals, and frequently asked questions for PFE, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - GENERAL

Exchange: NYSE

Key Metrics

Market Sentiment

Pfizer Inc currently has a Bullish sentiment score of 0.18.

About Pfizer Inc

Pfizer Inc. is a prominent global pharmaceutical and biotechnology company, based in New York City, with a rich history dating back to 1849. It excels in various therapeutic areas, including immunology, oncology, and cardiology, and is celebrated for its innovative approaches and robust pipeline of medications. Notably, Pfizer gained global recognition for its rapid development of the COVID-19 vaccine, playing a critical role in combating the pandemic and underscoring its commitment to addres...

GNG Research Analysis

GNG Research scores Pfizer Inc (PFE) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PFE.

Frequently Asked Questions

What is PFE's current dividend yield?

Pfizer Inc (PFE) has a current dividend yield of 0.07%.

Does PFE pay dividends?

Yes, Pfizer Inc pays dividends with a current yield of 0.07%.

What is PFE's P/E ratio?

Pfizer Inc has a price-to-earnings (P/E) ratio of 19.56.

What is PFE's market cap?

Pfizer Inc (PFE) has a market capitalization of $146.08B with a current stock price of $25.57.